Treatment outcomes of patients diagnosed with mental disorders after discharge from hospitalization during the covid-19 pandemic
- VernacularTitle:Ковид-19 цар тахлын үед эмнэлэгт хэвтэн эмчлүүлж гарсны дараа сэтгэцийн эмгэг оношилогдсон өвчтөнүүдийн эмчилгээний үр дүн
- Author:
Enkhtuvshin R
1
;
Mongoljin A
2
;
Munkh E
2
;
Uranchimeg M
2
;
Yelik M
2
;
Amirlan B
3
;
Yerkyebulan A
4
;
Munkh-Uchral D
4
;
Maidar E
5
;
Amarsaikhan A
6
;
Enkhnaran T
7
;
Оtgonbayar R
8
;
Nasantsengel L
1
;
Khishigsuren Z
1
Author Information
1. Department of Mental Health, School of Medicine, MNUMS
2. Department of Epidemiology and Biostatistics, School of Public Health, MNUMS
3. Department of clinical neuroscience, Brain and Mind Research Institute, MNUMS
4. National Center for Mental Health
5. Chingeltei District Health Center
6. National Forensic Agency
7. International Cyber Education Center, Graduate School, MNUMS
8. Department of Child Health, School of Medicine, MNUMS
- Publication Type:Journal Article
- Keywords:
COVID-19;
mental disorders;
treatment outcomes;
post-COVID psychological disorders;
statistical analysis
- From:Mongolian Medical Sciences
2025;213(3):3-14
- CountryMongolia
- Language:Mongolian
-
Abstract:
Background:The COVID-19 pandemic has triggered a global mental health crisis. According to WHO
estimates, anxiety and depression rose by 25% in the first year. In the post-COVID era, over
70% of patients experience depression, anxiety, insomnia, PTSD, and OCD, which can persist
for up to 24 months. Hospitalized individuals face heightened risks due to infection severity,
treatment stress, and social isolation. However, studies examining treatment outcomes and
influencing factors remain limited. In Mongolia, mental health issues escalated sharply from
2020 to 2022; WHO data indicate that anxiety and stress were prevalent among healthcare workers and patients. Children and youth were particularly affected, with UNICEF studies
emphasizing the urgent need for intervention. Suicide rates increased from 18.3 per 100,000.
Long-term research on post-COVID mental disorders is scarce, impeding policy formulation.
This study evaluates treatment outcomes in COVID patients and identifies key factors. By
comparing case and control groups at 3 and 12 months, it uncovers differences in symptoms
and treatment responses. The comparative design assesses statistical significance via
P-values and subgroup success rates for CBT and SSRI therapies. Findings will enhance
Mongolia’s mental health services. Larger-scale studies are essential moving forward.
Objective:To evaluate treatment outcomes for post-COVID mental disorders and identify influencing
factors. To analyze differences in psychological symptoms and treatment between case
(COVID-19 positive) and control groups over 3 and 12 months.
Material and Method:Retrospective comparative analysis of records from 281 patients (cases n=181, controls
n=100) at a unified hospital from 2020-2022. At 12 months, n=200 (cases n=100, controls
n=100). Patients were categorized by anxiety, depression, insomnia, and stress-related
symptoms, with P-values calculated. Detailed subgroup analysis (n=47 treated patients) was
conducted.
Results:At 3 months, cases showed higher anxiety (56.4%, P=0.002), depression (41.4%, P<0.001),
and insomnia (58%, P=0.107). At 12 months, differences lessened but anxiety (52%, P=0.023)
and depression (35%, P=0.042) remained significant. COVID-related new symptoms were
elevated in cases (e.g., depression 24.3%, P<0.001). Treatment subgroup success was
95.7% (P<0.001), with duration influencing outcomes (P=0.03).
Conclusion:Post-COVID mental symptoms persist long-term in cases, and extended treatment
durations yield better results. Larger studies are required
- Full text:2025122317523373514MAUS-2025-213(3)-3-14.pdf
